Evidence map›Paper›PMID 42724975›Full record

ArticleSurgical case reports2026

Laparoscopic Mesh-Salvage Fenestration for Chronic Symptomatic Seroma after Rives-Stoppa Incisional Hernia Repair: A Case Report.

Masanori Sato

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Masanori SatoDivision of General (Endoscopic) Surgery, Department of Surgery 1, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic encapsulated seroma after retromuscular incisional hernia repair can be difficult to manage, particularly in symptomatic patients without evidence of mesh infection. Open anterior capsulectomy may require wide mesh exposure and carries potential risks of mesh infection and recurrent incisional hernia. Herein, I report a case of a chronic symptomatic seroma successfully managed by laparoscopic mesh-salvage fenestration. CASE PRESENTATION: A 58-year-old man developed a chronic symptomatic seroma after open Rives-Stoppa repair for a midline incisional hernia. CT demonstrated an encapsulated fluid collection measuring approximately 10 × 7 cm dorsal to the rectus muscles, without signs of mesh infection. Because the symptoms persisted for 9 months despite repeated aspirations, laparoscopic fenestration through the posterior rectus sheath and retromuscular mesh was performed. Six fenestration openings were created to establish controlled communication between the seroma cavity and the peritoneal cavity. Percutaneous transfascial sutures were placed adjacent to the relatively larger defect to promote cavity collapse and reduce the potential risk of bowel incarceration. The postoperative course was uneventful. Follow-up MRI demonstrated substantial shrinkage of the chronic seroma cavity, with a small amount of asymptomatic omental protrusion through the mesh defect. Marked improvement in symptoms and QOL scores was observed after surgery.

conclusionsLaparoscopic fenestration through the posterior rectus sheath and retromuscular mesh may be a feasible, minimally invasive mesh-salvage option for selected patients with chronic symptomatic seroma after retromuscular incisional hernia repair in the absence of mesh infection.

Indexed as

chronic seromaincisional hernialaparoscopic fenestrationmesh salvageretromuscular mesh

Identifiers

PMID42724975
PMCPMC13561574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.